Marshall Wace
BIOA

Marshall Wace’s BioAge Labs BIOA Stock Holding History

Marshall Wace’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.33M Sell
190,472
-32,476
-15% -$625K ﹤0.01% 1515
2025
Q4 		$2.95M Buy
222,948
+48,752
+28% +$432K ﹤0.01% 1397
2025
Q3 		$1.02M Sell
174,196
-52,593
-23% -$246K ﹤0.01% 1932
2025
Q2 		$937K Buy
226,789
+173,388
+325% +$699K ﹤0.01% 1884
2025
Q1 		$201K Buy
+53,401
New +$247K ﹤0.01% 2405
2024
Q4 		– Sell
-200,000
Closed -$4.16M – 3082
2024
Q3 		$4.16M Buy
+200,000
New +$4.01M 0.01% 1066

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Marshall Wace's BIOA Position: Q1 2026 in Review

Marshall Wace reduced its BioAge Labs (BIOA) stake by 15% in Q1 2026, selling an estimated $625K and leaving 190,472 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

Marshall Wace first reported a position in BIOA in Q3 2024 and has held it in 6 quarters since. The position peaked at $4.16M in Q3 2024. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Marshall Wace held 190,472 shares of BioAge Labs worth $3.33M as of Q1 2026.
  • Marshall Wace sold 32,476 BioAge Labs shares in Q1 2026, an estimated $625K.
  • BioAge Labs made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1515 holding.
  • Marshall Wace first reported a position in BioAge Labs in Q3 2024 and has held it in 6 quarters since.
  • Marshall Wace's BioAge Labs position peaked at $4.16M in Q3 2024.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.